No association of FcγRIIa, FcγRIIIa and FcγRIIIb polymorphisms with MS

被引:8
|
作者
Breij, ECW
van der Pol, WL
van Winsen, L
Jansen, MD
Dijkstra, CD
van de Winkel, JGJ
Uitdehaag, BMJ
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Immunol, NL-3584 EA Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1081 HV Amsterdam, Netherlands
[5] Genmab, Utrecht, Netherlands
关键词
multiple sclerosis; Fc gamma receptors; polymorphisms;
D O I
10.1016/S0165-5728(03)00207-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-myelin IgGs occur in the cerebrospinal fluid (CSF) and serum of multiple sclerosis (MS) patients, and can induce inflammatory effector functions in leukocytes by crosslinking IgG receptors (FcgammaR). The efficiency of FcgammaR-mediated inflammatory processes is affected by functional polymorphisms of three Fcgamma receptors (FcgammaRIIa, FcgammaRIIIa, FcgammaRIIIb). The relevance of FcgammaR polymorphisms in MS was evaluated by studying the distribution of FcgammaRIIa, FcgammaRIIIa and FcgammaRIIIb genotypes in 432 MS patients and 515 healthy controls. No significant differences were found between MS patients and controls, or between subgroups of patients. We conclude that Fcgamma receptor polymorphisms influence neither susceptibility nor clinical disease course of MS. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 50 条
  • [1] FcγRIIA, FcγRIIIA and FcγRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus
    González-Escribano, MF
    Aguilar, F
    Sánchez-Román, J
    Núñez-Roldán, A
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2002, 29 (04): : 301 - 306
  • [2] FcγRIIA and FcγRIIIB polymorphisms in myasthenia gravis
    Raknes, G
    Skeie, GO
    Gilhus, NE
    Aadland, S
    Vedeler, C
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 81 (1-2) : 173 - 176
  • [3] Polymorphisms of Fcγ-receptors RIIa, RIIIa, and RIIIb in patients with adult periodontal diseases
    P Meisel
    LE Carlsson
    H Sawaf
    J Fanghaenel
    A Greinacher
    T Kocher
    Genes & Immunity, 2001, 2 : 258 - 262
  • [4] Polymorphisms of Fcγ-receptors RIIa, RIIIa, and RIIIb in patients with adult periodontal diseases
    Meisel, P
    Carlsson, LE
    Sawaf, H
    Fanghaenel, J
    Greinacher, A
    Kocher, T
    GENES AND IMMUNITY, 2001, 2 (05) : 258 - 262
  • [5] FcγRIIa and FcγRIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease
    Sclafani, Francesco
    de Castro, David Gonzalez
    Cunningham, David
    Wilson, Sanna Hulkki
    Peckitt, Clare
    Capdevila, Jaume
    Glimelius, Bengt
    Keraenen, Susana Rosello
    Wotherspoon, Andrew
    Brown, Gina
    Tait, Diana
    Begum, Ruwaida
    Thomas, Janet
    Oates, Jacqueline
    Chau, Ian
    CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4511 - 4519
  • [6] FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway
    Smith, I
    Vedeler, C
    Halstensen, A
    EPIDEMIOLOGY AND INFECTION, 2003, 130 (02): : 193 - 199
  • [7] FcγRIIa and FcγRIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients
    Costa Vigato-Ferreira, Isabel Cristina
    Toller-Kawahisa, Juliana Escher
    Tres Pancoto, Joao Alexandre
    Mendes-Junior, Celso Teixeira
    Martinez, Edson Zangiacomi
    Donadi, Eduardo Antonio
    Louzada-Junior, Paulo
    Cavalcanti Del Lama, Jose Eduardo
    Marzocchi-Machado, Cleni Mara
    AUTOIMMUNITY, 2014, 47 (07) : 451 - 458
  • [8] Involvement of immunoglobulin FcγRIIA and Fc-γRIIIB gene polymorphisms in susceptibility to rheumatic fever
    Berdeli, A
    Celik, HA
    Özyürek, R
    Aydin, HH
    CLINICAL BIOCHEMISTRY, 2004, 37 (10) : 925 - 929
  • [9] FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt
    Eyada, Tayseer K.
    Farawela, Hala M.
    Khorshied, Mervat M.
    Shaheen, Iman A.
    Selim, Neama M.
    Khalifa, Iman A. S.
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 64 - 68
  • [10] FCγRIIa and FCγRIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial
    Sclafani, F.
    Gollins, S.
    Cunningham, D.
    Wilson, S. Hulkki
    Kouvelakis, K.
    Lopes, A.
    West, N.
    Quirke, P.
    Begum, R.
    Valeri, N.
    Beare, S.
    Hughes, L.
    De Castro, D. Gonzalez
    Chau, I.
    ANNALS OF ONCOLOGY, 2017, 28